An interventional study of Standard Analgesia and Transcutaneous Electrical Nerve Stimulation (TENS) in Pain, Postoperative, sponsored by Buddhist Tzu Chi General Hospital. Completed at 1 site in Taiwan. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2026-10-21.
Sponsored by Buddhist Tzu Chi General Hospital · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 69 studies in Pain, Postoperative with a site in Taiwan — 20 open to participants now, 20 under way, 1 of them phase 3. Pain, Postoperative · Taiwan.
Among the 69 studies in Pain, Postoperative with a site in Taiwan, this one is the 18th largest by enrollment of the 62 interventional ones that give a count, is one of 5 that started in 2024, is one of 38 with no phase, and was the 61st registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →20 of the 69 studies in Pain, Postoperative with a site in Taiwan are open now. Recruiting first, the newest first:
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 18–75
Kaohsiung Medical University Chung-Ho Memorial Hospital · Sites in Taiwan
Ages 18+
Fooyin University · Sites in Taiwan
Ages 15–85
National Taiwan University Hospital Hsin-Chu Branch · Sites in Taiwan
Ages 20+
Dalin Tzu Chi General Hospital · Sites in Taiwan
Ages 20+ · Women only
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 15 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
69 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 5 · Phase 3 5 · Phase 4 15
First in 2004; this study’s year is marked. 5 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 96 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 71 across the 62 interventional studies, 150 across the 7 observational. Of the 30 that completed or were terminated, 4 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 69 have an industry lead sponsor. The 10 most frequent:
Buddhist Tzu Chi General Hospital is the lead sponsor of 88 studies on the registry; 20 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Buddhist Tzu Chi General Hospital has 2 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
5 of the studies in Pain, Postoperative with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05917262Chang Gung Memorial HospitalComparing Mindfulness-based Breath Training and Heart Rate Variability Biofeedback for Shoulder Surgery Patients in the Postoperative Pain. | 2026-12-31 |
| NCT07333040Chang Gung Memorial HospitalHELO Trial: Energy-Based Therapies vs. Conventional Hemorrhoidectomy for Grade III Hemorrhoids | 2027-05-01 |
| NCT07191964Taipei Medical University WanFang HospitalEfficacy of an AFCN Proxy Block in Post-TKA Multimodal Pain Management | 2027-08-01 |
| NCT06426251National Taiwan University Hospital Hsin-Chu BranchPhotobiomodulation Therapy in Patients Receiving Total Knee Arthroplasty | 2027-09-01 |
| NCT07306546Kaohsiung Medical University Chung-Ho Memorial HospitalEffectiveness of Hydrogen Water Intervention on Acute Oral Inflammation, Oral Microbiota, and Pain Following Free Flap Reconstruction in Patients With Oral Cancer | 2027-10-31 |
Add all 5 to your calendar (.ics) → With an account.
Among the 69 studies in Pain, Postoperative with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Thoracic surgery is known to be one of the most painful types of surgery. If acute postoperative pain is not properly managed, there is a high risk that it may develop into clinically significant chronic pain within six months after surgery, which can seriously affect quality of life. According to research on Enhanced Recovery After Surgery (ERAS), using multimodal pain management strategies can significantly reduce postoperative pain and decrease reliance on pain medications. This study aims to investigate whether combining transcutaneous Electrical Nerve Stimulation therapy with conventional pain management can further enhance pain relief and improve recovery outcomes.
This study aims to evaluate the efficacy of three postoperative analgesic strategies in patients undergoing lesion resection via video-assisted thoracoscopic surgery (VATS). Under standard postoperative care protocols, patients will be randomized into three groups: (1) conventional pharmacologic analgesia alone, (2) conventional analgesia combined with transcutaneous electrical nerve stimulation (TENS), and (3) conventional analgesia combined with both transcutaneous electrical nerve stimulation (TENS) and transcutaneous electrical acupoint stimulation (TEAS). The primary outcomes include the assessment of acute postoperative pain intensity, blood inflammatory biomarkers, health-related quality of life, and the incidence of postoperative complications. This investigation seeks to determine whether adjunctive use of neuromodulatory techniques such as TENS and TEAS can enhance analgesic efficacy and improve postoperative recovery profiles.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants receive standard postoperative analgesia according to institutional protocol.
Drug: Standard Analgesia
Participants receive standard postoperative analgesia combined with transcutaneous electrical nerve stimulation (TENS)
Drug: Standard Analgesia · Device: Transcutaneous Electrical Nerve Stimulation (TENS)
Participants receive standard postoperative analgesia combined with both transcutaneous electrical nerve stimulation (TENS) and transcutaneous electrical acupoint stimulation (TEAS).
Drug: Standard Analgesia · Device: Transcutaneous Electrical Nerve Stimulation (TENS) · Device: Transcutaneous Electrical Acupoint Stimulation (TEAS)
Postoperative analgesic medications administered according to standard clinical practice and hospital guidelines
Non-invasive electrical nerve stimulation therapy applied to specific areas to reduce postoperative pain
Electrical stimulation applied to specific acupuncture points through the skin to enhance analgesic efficacy and modulate autonomic function.
Postoperative Pain Intensity Assessed Using the Visual Analog Scale (VAS)
Pain intensity will be assessed using a 10-point Visual Analog Scale (VAS), where 0 indicates "no pain" and 10 indicates "worst imaginable pain."
Time frame: Within 48 hours after surgery
Blood Inflammatory Markers
Blood inflammatory markers, including the neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR), will be calculated using complete blood count (CBC) parameters. NLR increases are commonly interpreted as indicators of elevated systemic inflammation, whereas decreases in LMR may reflect enhanced inflammatory activity or physiological stress following surgery. These ratios will be assessed at multiple perioperative time points to evaluate changes in inflammatory response. The relationship between postoperative pain levels, clinical recovery, and changes in NLR and LMR will be analyzed to determine whether inflammatory activation is associated with greater postoperative pain or adverse outcomes. Units of measure are expressed as ratios (NLR, LMR).
Time frame: Within 48 hours after surgery
Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (HADS) will be used to evaluate participants' psychological status during the perioperative period. The scale consists of 14 items, with 7 items assessing anxiety (HADS-A) and 7 items assessing depression (HADS-D). Each item is scored from 0 to 3, yielding subscale scores ranging from 0 to 21. Higher scores indicate greater levels of anxiety or depression. Changes in HADS-A and HADS-D scores will be analyzed to determine postoperative psychological responses and the potential impact of different analgesic interventions.
Time frame: At baseline (preoperative), and after surgery 6 and 48 hours later
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Undecided — Because it is still underway, I will share it after the research is completed.
Ran from May 2024 to primary completion in Sep 2025, 16 months.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 16 months is above that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 21, 2026: primary completion Dec 2025 → Sep 2025 and completion Dec 2025 → Sep 2025.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Buddhist Tzu Chi General Hospital